| NCT ID | NCT06915584 |
| Status | Recruiting |
| Phase | — |
| Sponsor | IRCCS San Raffaele Roma |
| Condition | Heart Failure |
| Study Type | OBSERVATIONAL |
| Enrollment | 450 participants |
| Start Date | 2024-11-30 |
| Primary Completion | 2025-06-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 450 participants in total. It began in 2024-11-30 with a primary completion date of 2025-06-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Aim of the proposal is to create an interactive AI-based multicentre prospective database to provide information on how to improve the QoC for pts with HF.This will provide detailed information on pts characteristics,treatment practices, adherence to prescribed guideline-based optimal drug therapy,and outcomes.The database stems from a registry started two years ago,conceived to provide a contemporary snapshot on the adherence to the latest European GGLL for the therapeutic management of pts with HF.The database will be integrated with a specifically designed algorithm that provides an accurate feedback on whether patients are properly treated according to the ESC most recent recommendations.The expected outcomes are:-define non-adherence level to GGLL-based recommendations for treatment of HF;-provide information on initiation, adherence and persistence over time of the recommended treatment;-reduce medical inertia;produce practical implications to reduce morbidity and mortality
Eligibility Criteria
Inclusion Criteria: * Both gender * Age \>18 years * Signed informed consent for the study * Known diagnosis of heart failure \> 6 months * Recent or ongoing hospitalization for heart failure exacerbation Exclusion Criteria: * Conditions that, in the investigator's judgment, may interfere with the study or contraindicate participation for safety reasons * Concurrent diagnosis of neoplasia * Advanced COPD (FEV1 \<50%) * Advanced valvular heart disease (severe mitral-aortic stenosis-insufficiency requiring cardiac surgery)
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06915584 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Heart Failure. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06915584 currently recruiting?
Yes, NCT06915584 is actively recruiting participants. Contact the research team at lucia.gatta@sanraffaele.it for enrollment information.
Where is the NCT06915584 trial being conducted?
This trial is being conducted at Rome, Italy.
Who is sponsoring the NCT06915584 clinical trial?
NCT06915584 is sponsored by IRCCS San Raffaele Roma. The trial plans to enroll 450 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.